Category «EU 2021»

Lenalidomide hydrate

It’s only fair to share… Lenalidomide hydrate レナリドミド水和物 An immunomodulator. CC-5013 hemihydrate 2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-, hydrate (2:1) (+/-)-2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-, hydrate (2:1) Formula (C13H13N3O3)2. H2O CAS 847871-99-2 Mol weight 536.5365 EMA APPROVED 2021/2/11,  Lenalidomide KRKA Research Code:CDC-501; CC-5013 Trade Name:Revlimid® MOA:Angiogenesis inhibitor Indication:Myelodysplastic syndrome (MDS); Mantle cell lymphoma (MCL); Multiple myeloma (MM) Status:Approved Company:Celgene (Originator) Sales:$5,801.1 Million (Y2015);  $4,980 Million (Y2014);; $4280 …